Omega Healthcare Investors, Inc.
OHIReal Estate Reit Healthcare Facilities
Omega Healthcare Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 13.2% from fiscal 2024.
- Revenue
- +9.30%
- EPS
- −54.2%
- Free cash flow
- n/m
- Total debt
- −19.5%
Quarter to September 2026, against a year earlier
After hours trading: 45.09, down 0.97%, last trade 7:27pm Eastern.
Follow OHI
Alert me
Ratios over time Q4 FY25 to Q3 FY26
Returns on capital
ROIC was 4.65% in Q3 FY26, the lowest of these four quarters. ROE, at 14.1%, is far above it because equity is small against the capital the business uses.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| ROE | 11.6% | 12.2% | 16.1% | 14.0% |
| ROIC | 8.0% | 4.9% | 9.1% | 4.6% |
Debt
Net debt is 18.37× a year’s EBITDA. Debt is 0.70× equity, against 0.81× in Q1 FY26.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Debt / equity | 0.0× | 0.8× | 0.0× | 0.7× |
| Net debt / EBITDA | 0.7× | 15.7× | −0.6× | 18.4× |
Per share, from Q4 FY25
Since Q4 FY25, per share: free cash flow has grown 299.1%; revenue has grown 5.72%; book value has grown 1.67%.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Free cash flow | 1.0× | 0.9× | 10.0× | 4.0× |
| Revenue | 1.0× | 1.0× | 1.1× | 1.1× |
| Book value | 1.0× | 1.0× | 1.0× | 1.0× |
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
22.74 | 21.07 | 16.85 | 18.52 |
P/S ratio |
10.87 | 10.53 | 11.11 | 10.73 | |
P/FCF ratio |
159.52 | 184.85 | 17.12 | 41.74 | |
P/Operating CF |
56.07 | 60.40 | 65.45 | 73.67 | |
P/B ratio |
2.38 | 2.39 | 2.53 | 2.44 | |
Price to Tangible BV |
2.70 | 2.71 | 2.85 | 2.75 | |
EV/Sales |
11.02 | 14.08 | 10.98 | 13.63 | |
EV/EBITDA |
12.57 | 15.81 | 12.45 | 17.03 | |
EV/Operating CF |
14.93 | 19.08 | 15.80 | 20.90 | |
EV/FCF |
161.84 | 247.17 | 16.91 | 53.00 | |
Quick Ratio |
1.89 | 1.21 | 2.10 | 2.23 | |
Current Ratio |
5.81 | 5.32 | 6.03 | 6.22 | |
Net Debt/EBITDA |
0.68 | 15.68 | (0.62) | 18.37 | |
Debt/Assets |
2.41% | 43.40% | 0.06% | 39.73% | |
Debt/Equity |
0.04 | 0.81 | 0.00 | 0.70 | |
Asset Turnover |
0.12 | 0.12 | 0.12 | 0.13 | |
Operating CF/Net income |
1.35 | 1.54 | 0.58 | 2.24 | |
Capex/Depreciation |
(1.05) | (1.85) | 4.44 | (8.58) | |
Interest Coverage |
3.78 | 4.13 | 3.92 | 2.72 | |
Selling, General and Administrative Expense of Revenue |
7.99% | 8.06% | 12.79% | 11.62% | |
Intangible Assets out of Total Assets |
0.06 | 0.06 | 0.06 | 0.06 | |
Share Based Compensation of Revenue |
3.09% | 3.28% | 7.14% | 6.96% | |
Graham Net Nets |
(0.20) | (0.23) | (0.16) | (0.16) | |
Graham Number |
28.61 | 29.32 | 34.67 | 32.66 | |
Earnings Yield |
4.40% | 4.75% | 5.94% | 5.40% | |
Free Cash Flow Yield |
0.63% | 0.54% | 5.84% | 2.40% | |
Revenue per Share |
1.09 | 1.09 | 1.10 | 1.12 | |
Operating CF per Share |
0.79 | 0.73 | 0.73 | 0.63 | |
Capex per Share |
(0.29) | (0.46) | 1.46 | (2.41) | |
Free Cash Flow per Share |
0.50 | 0.26 | 2.19 | (1.78) | |
Cash per Share |
0.19 | 0.18 | 0.62 | 0.74 | |
Shareholders Equity per Share |
18.65 | 18.36 | 18.88 | 18.97 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
18.65 | 18.36 | 18.88 | 18.97 | |
Free Cash Flow |
146.63 | 77.69 | 654.61 | (541.77) | |
Working Capital |
1,694.06 | 1,459.70 | 1,749.35 | 1,761.65 | |
Capital Expenditures |
(83.99) | (137.82) | 436.89 | (732.80) | |
Net Current Asset Value |
(2,561.95) | (2,981.59) | (2,275.26) | (2,259.27) | |
EV/EBIT |
18.29 | 22.63 | 17.72 | 25.13 | |
Capex to Sales |
0.26 | 0.43 | (1.33) | 2.15 | |
Price to Operating Income |
18.03 | 16.93 | 17.94 | 19.79 | |
| Other line items | |||||
Average Receivables |
477.99 | 349.32 | 445.58 | 440.98 | |
Average Assets |
9,973.48 | 9,970.14 | 10,280.62 | 10,358.64 | |
Average Common Equity |
5,085.67 | 5,193.52 | 5,415.65 | 5,503.57 |